APA

Nout R. A., Smit V. T. H. B. M., Putter H., Jürgenliemk-Schulz I. M., Jobsen J. J., Lutgens L. C. H. W., van der Steen-Banasik E. M., Mens J. W. M., Slot A., Kroese M. C. S., van Bunningen B. N. F. M., Ansink A. C., van Putten W. L. J. & Creutzberg C. L. (20100323). Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. : Lancet (London, England).

Chicago

Nout R A, Smit V T H B M, Putter H, Jürgenliemk-Schulz I M, Jobsen J J, Lutgens L C H W, van der Steen-Banasik E M, Mens J W M, Slot A, Kroese M C Stenfert, van Bunningen B N F M, Ansink A C, van Putten W L J and Creutzberg C L. 20100323. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. : Lancet (London, England).

Harvard

Nout R. A., Smit V. T. H. B. M., Putter H., Jürgenliemk-Schulz I. M., Jobsen J. J., Lutgens L. C. H. W., van der Steen-Banasik E. M., Mens J. W. M., Slot A., Kroese M. C. S., van Bunningen B. N. F. M., Ansink A. C., van Putten W. L. J. and Creutzberg C. L. (20100323). Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. : Lancet (London, England).

MLA

Nout R A, Smit V T H B M, Putter H, Jürgenliemk-Schulz I M, Jobsen J J, Lutgens L C H W, van der Steen-Banasik E M, Mens J W M, Slot A, Kroese M C Stenfert, van Bunningen B N F M, Ansink A C, van Putten W L J and Creutzberg C L. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. : Lancet (London, England). 20100323.